Cost-effective Amperometric Immunosensor for cardiac troponin I as a step towards affordable point-of-care diagnosis of acute myocardial infarction

Early detection of cardiac troponin I in blood is vital for acute myocardial infarction diagnosis. A low-cost thin film gold electrode array was used with affordable ELISA antibodies and reagents to fabricate two cardiac troponin I amperometric immunosensors. The HRP-labelled sandwich immunocomplex was constructed on the gold electrode surface, and chronoamperometry was used to quantify cTnI indirectly by measuring the amount of TMB + produced at the electrode surface. First, the system was evaluated using a physisorption approach to immobilise the capture antibody to the electrode with a 309 pg/mL LOD observed. Subsequently, a second sensor variant was produced using sulfo-LC-SPDP as a crosslinker to control antibody immobilisation, which resulted in an improved sensitivity with an LOD of 109 pg/mL. The chemisorption sensor outperformed the working range of the commercially available ELISA kit used (8000–125 pg/mL), demonstrating the power of enhanced antibody immobilisation and electrochemical detection for clinically relevant levels of cardiac troponin I. Amperometric immunosensors offer vital advantages including being cost-effective, simple to use, and compatible with commercially available reagents. These features make the sensor accessible to users and easy to manufacture. With further improvements to sensitivity and performance in complex samples, the sensor could be deployed to streamline acute myocardial infarction diagnosis and reduce the burden of chest pain patients on the healthcare system. • An affordable ELISA kit was repurposed to fabricate two cTnI sensors using gold film electrode arrays. • A physisorption sensor was fabricated, then enhanced with Sulfo-LC-SPDP for better capture antibody immobilisation. • The chemisorption sensor surpassed the ELISA range and detected clinically relevant concentrations of cTnI. • This work is the first step towards a robust and simple electrochemical ELISA for point of care cTnI detection.

Authors

Institutions

Publication Details

Journal
Sensing and Bio-Sensing Research
Published
2024-12-22
DOI
https://doi.org/10.1016/j.sbsr.2024.100725
Citations
7
Primary Topic
Advanced biosensing and bioanalysis techniques
Type
article
Field-Weighted Citation Impact
1.64
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cost-effective Amperometric Immunosensor for cardiac troponin I as a step towards affordable point-of-care diagnosis of acute myocardial infarction

Neil G. Docherty, Ying Fu, Damion K. Corrigan, Louise Collins et al.
7 citations
Sensing and Bio-Sensing Research
Advanced biosensing and bioanalysis techniques
1.64
article

Cost-effective Amperometric Immunosensor for cardiac troponin I as a step towards affordable point-of-care diagnosis of acute myocardial infarction

Neil G. Docherty, Ying Fu, Damion K. Corrigan, Louise Collins, Stuart Milne, Susan Pang
article en
7 citations

Abstract

Early detection of cardiac troponin I in blood is vital for acute myocardial infarction diagnosis. A low-cost thin film gold electrode array was used with affordable ELISA antibodies and reagents to fabricate two cardiac troponin I amperometric immunosensors. The HRP-labelled sandwich immunocomplex was constructed on the gold electrode surface, and chronoamperometry was used to quantify cTnI indirectly by measuring the amount of TMB + produced at the electrode surface. First, the system was evaluated using a physisorption approach to immobilise the capture antibody to the electrode with a 309 pg/mL LOD observed. Subsequently, a second sensor variant was produced using sulfo-LC-SPDP as a crosslinker to control antibody immobilisation, which resulted in an improved sensitivity with an LOD of 109 pg/mL. The chemisorption sensor outperformed the working range of the commercially available ELISA kit used (8000–125 pg/mL), demonstrating the power of enhanced antibody immobilisation and electrochemical detection for clinically relevant levels of cardiac troponin I. Amperometric immunosensors offer vital advantages including being cost-effective, simple to use, and compatible with commercially available reagents. These features make the sensor accessible to users and easy to manufacture. With further improvements to sensitivity and performance in complex samples, the sensor could be deployed to streamline acute myocardial infarction diagnosis and reduce the burden of chest pain patients on the healthcare system. • An affordable ELISA kit was repurposed to fabricate two cTnI sensors using gold film electrode arrays. • A physisorption sensor was fabricated, then enhanced with Sulfo-LC-SPDP for better capture antibody immobilisation. • The chemisorption sensor surpassed the ELISA range and detected clinically relevant concentrations of cTnI. • This work is the first step towards a robust and simple electrochemical ELISA for point of care cTnI detection.

Sensing and Bio-Sensing ResearchVol. 47
National Physical Laboratory (GB), University of Strathclyde (GB)
Zero hunger
Openalex Percentile: Top 16%
Advanced biosensing and bioanalysis techniques
1.64
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.